0A91 Stock Chart & Stats
$48.66
$0.35(0.71%)
At close: 4:00 PM EDT
$48.66
$0.35(0.71%)
Day’s Range― - ―
52-Week Range$35.71 - $99.77
Previous CloseN/A
Volume10.37K
Average Volume (3M)5.76K
Market Cap
$3.71B
Enterprise Value$5.21K
Total Cash (Recent Filing)$380.30M
Total Debt (Recent Filing)$206.40M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 10, 2026EPS Estimate
-0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.87
Shares Outstanding76,820,786
10 Day Avg. Volume4,747
30 Day Avg. Volume5,758
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)9.58
Price to Sales (P/S)6.93
P/FCF Ratio-197.38
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$64.20Price Target Upside31.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)-1.82
Revenue Forecast (FY)$1.22B
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Market TractionSustained double‑digit revenue growth reflects accelerating policy sales and higher premium retention, showing product-market fit across lines. This durable top-line momentum supports scale economics and funds continued investment in distribution and product expansion.
Improving Unit Economics And MarginsMaterial improvement in gross profit and adjusted gross margins demonstrates structural gains in underwriting economics and pricing power. Combined with low LAE and AI automation, these margin gains are likely to persist as scale and product mix shifts toward higher‑ARP lines like pet insurance.
Growth Financing & Liquidity SupportA structured growth financing facility provides durable, non‑equity capital to fund customer acquisition and scale marketing without immediate dilution. It strengthens capital planning, enables disciplined cohort funding, and supports faster scaling of in‑force premium while preserving balance sheet liquidity.
Bears Say
Persisting GAAP Losses And Negative ROEOngoing GAAP net losses and negative returns on equity constrain capital resilience and limit optionality. Until GAAP profitability and ROE turn positive, the firm faces pressure to raise capital or accept dilution, which can impede long‑term strategic flexibility.
Weak Underwriting (high Combined Ratio)A combined ratio materially above peers signals underwriting economics that still lose money before investment income. This structural shortfall requires sustained pricing, product repricing, or reinsurance changes to secure durable profitability even as revenue grows.
Rising Operating Expense And Equity CompensationA marked increase in stock‑based pay and rising operating costs elevates fixed expense run‑rate and potential dilution. These structural cost elements can offset margin gains from underwriting and slow the path to sustained net profitability if productivity gains don’t outpace expense growth.
Lemonade News
0A91 FAQ
What was Lemonade’s price range in the past 12 months?
Lemonade lowest share price was $35.71 and its highest was $99.77 in the past 12 months.
What is Lemonade’s market cap?
Lemonade’s market cap is $3.71B.
When is Lemonade’s upcoming earnings report date?
Lemonade’s upcoming earnings report date is Nov 10, 2026 which is in 99 days.
How were Lemonade’s earnings last quarter?
Lemonade released its earnings results on Jul 29, 2026. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.564 by $0.004.
Is Lemonade overvalued?
According to Wall Street analysts Lemonade’s price is currently Undervalued.
Does Lemonade pay dividends?
Lemonade does not currently pay dividends.
What is Lemonade’s EPS estimate?
Lemonade’s EPS estimate is -0.59.
How many shares outstanding does Lemonade have?
Lemonade has 76,820,786 shares outstanding.
What happened to Lemonade’s price movement after its last earnings report?
Lemonade reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.564. Following the earnings report the stock price went down -19.988%.
Which hedge fund is a major shareholder of Lemonade?
Currently, no hedge funds are holding shares in GB:0A91
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lemonade Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$64.20 (31.94% Upside)
$64.20 (31.94% Upside)
Blogger Sentiment
Bullish
GB:0A91 Sentiment 83%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $275.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 62%
Bearish news 38%
Bearish news 38%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.27%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.93%
Trailing 12-Months
Company Description
Lemonade
Lemonade, Inc. functions as an insurance provider operating across the United States and Europe, offering a diverse array of policies. Their core coverage options encompass protection against stolen or damaged personal property, as well as personal liability insurance designed to safeguard customers if they are deemed responsible for accidents or harm to others or their assets. Specifically, they provide renters, homeowners, pet, auto, life, and landlord insurance products. Additionally, the company extends its services by acting as an agent for other insurance carriers. Founded in 2015 as Lemonade Group, Inc., the New York-headquartered firm later adopted its current name, Lemonade, Inc.
0A91 Company Deck
0A91 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong and accelerating top-line growth (IFP +32% YoY, revenue +71% YoY), substantial expansion in gross profit (+159%) and improving profitability measures (adjusted EBITDA loss narrowed 64% and adjusted free cash flow positive). Management highlighted sustainable unit economics (LTV:CAC >3), operational leverage from AI-driven automation (IFP per employee >$1M, LAE ~6%), and material progress in key product lines (Pet IFP $500M). Key challenges remain: a relatively high gross loss/combined ratio (~138% combined per analyst), rising operating expenses and stock-based comp, ADR pressure from prior book clean-up, and remaining GAAP net losses. Given the pronounced improvements in growth, margins, cash flow, and explicit targets toward breakeven (positive EBITDA quarter expected in Q4), the positive developments materially outweigh the lingering lowlights.View all GB:0A91 earnings summaries0A91 Stock 12 Month Forecast
Average Price Target
$64.20
▲(31.94% Upside)